In this study, the complex associations between PCK1 and metabolic and nonmetabolic processes in tumors are reviewed, and the influence of changes in PCK1 on the metabolic diversity and targeted dependence of the whole tumor is emphasized, which provides a new perspective for improving cancer diagnosis and treatment. This evidence concerns the gene PCK1 and neoplasm.